DocGo Inc. (DCGO)

NasdaqCM: DCGO · リアルタイム株価 · USD

0.71

+0.04 (5.97%)

終値時点： Aug 17, 2026, 8:00 PM

0.61

-13.39%

時間外: 7:59 PM

5.97% (1D)

データがありません

買気配	0.48
時価総額	70.14M
売上高（TTM）	301.71M
純利益（TTM）	-187.76M
ベータ	0.99
EPS（TTM）	-1.9
PER（TTM）	n/a
予想PER	13.95
PBR（TTM）	0.53
PSR（TTM）	0.23
Earnings Date	Aug 17, 2026

売気配	0.87
出来高	1,644,536
平均出来高（20日）	772,653
始値	0.68
前日終値	0.67
当日レンジ	0.66 - 0.72
52週レンジ	0.45 - 1.73
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

DCGOについて

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are p...

[続きを読む]

業種 Medical Care Facilities

セクター Healthcare

IPO日 Dec 17, 2020

従業員数 2,537

上場取引所 NasdaqCM

ティッカー DCGO

ウェブサイト https://docgo.com

企業情報の全文

業績

2025年のDocGoの売上高は322.2Mで、前年の616.56Mから-47.74%の減少でした。利益は-182.4Mで、-1,012.36%の減少でした。

財務諸表

決算サプライズ

DocGoはAug 17, 2026に四半期決算を発表しました：

売上高は $75.55M で、予想を下回りました $0, うち -21.33% の前年比減少.

EPSは -0.26 で、予想を下回りました -0.11, うち -23.81% の前年比減少.

ニュース

1日前 · MarketBeat

DocGo Q2 Earnings Call Highlights

DocGo (NASDAQ:DCGO) reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related ...

1日前 · Zacks

DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates

Motion Acquisition (DCGO) delivered earnings and revenue surprises of +500.00% and -2.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

5日前 · Zacks

Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates

Lifeward (LFWD) delivered earnings and revenue surprises of +2.01% and -10.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

5日前 · Zacks

Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +71.43% and +45.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2週間前 · Zacks

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc...

2ページ中1ページ

DocGo Inc. (DCGO)

DCGOについて